Table 1. General Characteristics of All Patients.
| Results | |
|---|---|
| Age, mean ± SD, y | 66.1 ± 12.14 |
| Sex, No. (%), Male/Female | 267 (73.6)/96(26.4) |
| Etiology, No. (%) | |
| HBV a | 98 (28.7) |
| HCVa | 165 (48.2) |
| Combined HBV + HCV | 6 (1.8) |
| None Viral Etiology | 73 (21.3) |
| CPT a Class, No. (%) | |
| A | 101 (29.5) |
| B | 152 (44.4) |
| C | 89 (26.0) |
| Ascites, No. (%) | |
| No | 146 (40.6) |
| Mild-Moderate | 157 (43.6) |
| Severe | 53 (15.8) |
| Hepatic Encephalopathy, No. (%) | |
| None | 303 (85.8) |
| Grade 1-2 | 34 (9.6) |
| Grade 3-4 | 16 (4.5) |
| Significant PHT | 195 (54.9) |
| Albumin, No. (%) | |
| < 30, g/L | 190 (52.3) |
| ≥ 30, g/L | 173 (47.7) |
| AFP a , No. (%) | |
| < 400, ng/ml | 207 (64.1) |
| ≥ 400, ng/ml | 116 (35.9) |
| ALT a , median (range), U/L | 59 (7-1216) |
| AST a , median (range), U/L | 80.5 (11-1309) |
| GGT a , median (range), U/L | 141.5 (10-1861) |
| ALP a , median (range), U/L | 188 (27-1770) |
| Bilirubin, median (range), µmol/L | 25 (2-500) |
| Platelet Count, median (range), x109/L | 158 (33-790) |
| INR a , median (range) | 1.2 (0.9-4.1) |
aAbbreviations: AFP, alpha-fetoprotein; AST, aspartate aminotransferase; ALP, alkaline phosphatase; ALT, alanine aminotransferase; CPT, Child-Turcotte-Pugh score; GGT, gamma glutamyl transpeptidase; HBV, hepatitis B virus; HCV, hepatitis C virus; INR, international normalized ratio; PHT, portal hypertension